Based on recent data, Jade Biosciences, Inc. (JBIO) shows an Average True Range (ATR) of 1.04 and an Enterprise Value of N/A. Its average trading volume over the past 3 months is 283.39K, indicating liquidity. These fundamental metrics provide insight into JBIO's underlying financial health and market activity.
| ATR | 1.04 |
| Enterprise Value | - |
| Avg Vol (3 Months) | 283.39K |
| Avg Vol (10 Days) | 342.75K |
Jade Biosciences, Inc. (JBIO) technical indicators as of January 12, 2026: the SMA 20 is -11.05%, SMA 50 at 5.33%, and SMA 200 at 39.85%. The RSI 14 value is 44.33, suggesting its current momentum. These technical analysis signals help assess JBIO's price trends and potential future movements.
| SMA 20 | -11.05% |
| SMA 50 | 5.33% |
| SMA 200 | 39.85% |
| RSI 14 | 44.33 |
Jade Biosciences, Inc. (JBIO) stock performance overview as of January 12, 2026: The 52-week high is $17.71 (currently -23.6% below), and the 52-week low is $6.57 (currently 106.09% above). Over the past year, JBIO's performance is N/A, compared to the S&P 500's 12.34% change.
| 52-Week High | 17.71 |
| 52-Week High Chg | -23.60% |
| 52-Week Low | 6.57 |
| 52-Week Low Chg | +106.09% |
| S&P 500 52-Week Chg | 12.34% |
According to market data, Jade Biosciences, Inc. (JBIO) stock's recent performance metrics show that over the last month, JBIO is -1.85%, with a Year-to-Date (YTD) performance of -14.13%. Over the past year, the stock has seen a N/A change. These figures summarize JBIO's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 14.13 | 17.71 | 17.71 | 17.71 | 17.71 | 15.93 |
| Low | 12.52 | 12.52 | 8.36 | 6.67 | 6.57 | 12.52 |
| Performance | -14.13% | -1.85% | +46.57% | +26.07% | - | -14.13% |
According to current financial data, JBIO stock's P/E (TTM) ratio is -8.21, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.24. Key valuation ratios for JBIO, including P/S (N/A), P/B (2.99), and P/FCF (-5.76), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | JBIO | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | -8.21 | -1.24 | -5.16 | 32.59 |
| P/S (TTM) | N/A | 3.71 | 465.9 | 5.98 |
| P/B (TTM) | 2.99 | 0.19 | -335.2 | 6.24 |
| P/FCF (TTM) | -5.76 | -8.97 | -394.53 | 36.55 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep